Page last updated: 2024-09-02

fingolimod hydrochloride and Cell Transformation, Neoplastic

fingolimod hydrochloride has been researched along with Cell Transformation, Neoplastic in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aye, JM; Beierle, EA; Friedman, GK; Garner, EF; Moore, BP; Mroczek-Musulman, E; Stafman, LL; Stewart, JE; Williams, AP	1
Allegood, JC; Avni, D; Hait, NC; Harikumar, KB; Huang, WC; Kim, EY; Kordula, T; Liang, J; Milstien, S; Nagahashi, M; Price, MM; Spiegel, S; Takabe, K; Yamada, A	1
Herzinger, T; Kleuser, B; Korting, HC; Schäfer-Korting, M	1

Reviews

1 review(s) available for fingolimod hydrochloride and Cell Transformation, Neoplastic

Article	Year
Sphingosine-1-phosphate signaling and the skin. American journal of clinical dermatology, 2007, Volume: 8, Issue:6 Topics: Acne Vulgaris; Animals; Cell Transformation, Neoplastic; Connective Tissue; Epidermis; Fingolimod Hydrochloride; Humans; Immunity; Immunosuppressive Agents; Lysophospholipids; Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Skin; Sphingosine; T-Lymphocytes	2007

Article

Year

Sphingosine-1-phosphate signaling and the skin.

American journal of clinical dermatology, 2007, Volume: 8, Issue:6

Topics: Acne Vulgaris; Animals; Cell Transformation, Neoplastic; Connective Tissue; Epidermis; Fingolimod Hydrochloride; Humans; Immunity; Immunosuppressive Agents; Lysophospholipids; Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Skin; Sphingosine; T-Lymphocytes

2007

Other Studies

2 other study(ies) available for fingolimod hydrochloride and Cell Transformation, Neoplastic

Article	Year
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts. Scientific reports, 2018, 05-02, Volume: 8, Issue:1 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Disease Models, Animal; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Humans; Medulloblastoma; Mice; Xenograft Model Antitumor Assays	2018
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer cell, 2013, Jan-14, Volume: 23, Issue:1 Topics: Animals; Cell Transformation, Neoplastic; Colitis; Colon; Fingolimod Hydrochloride; Gene Deletion; Gene Expression Regulation, Neoplastic; Interleukin-6; Lysophospholipids; Mice; NF-kappa B; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Sphingosine; STAT3 Transcription Factor; Tumor Microenvironment	2013

Article

Year

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts.

Scientific reports, 2018, 05-02, Volume: 8, Issue:1

Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Disease Models, Animal; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Humans; Medulloblastoma; Mice; Xenograft Model Antitumor Assays

2018

Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.

Cancer cell, 2013, Jan-14, Volume: 23, Issue:1

Topics: Animals; Cell Transformation, Neoplastic; Colitis; Colon; Fingolimod Hydrochloride; Gene Deletion; Gene Expression Regulation, Neoplastic; Interleukin-6; Lysophospholipids; Mice; NF-kappa B; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Sphingosine; STAT3 Transcription Factor; Tumor Microenvironment

2013